AI-designed drugs will require new regulatory science approaches.
open
Global / Unspecified, Global
Models may generate candidate molecules rapidly, challenging traditional assessment. Simulation-based validation and adaptive regulatory frameworks will be needed.
Citation ID: WS02063
Title: AI-designed drugs will require new regulatory science approaches.
URL: https://www.worldsolve.org/index.php?api=problem&id=2063